The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that work by stimulating the tibial nerve.

Edwards terminated the deal after the Federal Trade Commission moved to block the acquisition due to anticompetitive concerns ...

The company unveiled the appointment alongside news of the departure of its chief commercial officer.

The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular ...

CMR Surgical received the approval for abdominal surgery for its Versius platform in patients under age 18 in Europe, while ...

The Teleflex veteran has left the company without a permanent successor. Teleflex has made Stuart Randle, a board member, ...

In a pair of guidance documents released Tuesday, the regulator clarified the types of wellness features and clinical ...

From insurance coverage questions to M&A and tariffs, here are the top storylines to watch in the medical device space in ...

The China-based surgical robot manufacturer is gearing up for growth after receiving Europe’s CE mark last year for its ...

Johnson & Johnson’s filing comes a month after Medtronic gained U.S. clearance for its Hugo system as competition in the soft ...

Stereotaxis’ CEO said the company has been “hampered clinically, commercially and strategically” by its prior dependence on a ...